Lux Health Tech Acquisition Corp. (LUXA)
| Market Cap | 410.25M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 37.50M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 22 |
| Last Price | $10.94 |
| Previous Close | $10.97 |
| Change ($) | -0.03 |
| Change (%) | -0.27% |
| Day's Open | 11.00 |
| Day's Range | 10.91 - 11.59 |
| Day's Volume | 95,510 |
| 52-Week Range | 10.30 - 11.59 |
News
Eleven IPOs and nine SPACs priced this past week, getting out ahead of the US election. Markets tumbled and volatility spiked, as several deals broke issue and three IPOs postponed.
NEW YORK--(BUSINESS WIRE)--Lux Health Tech Acquisition Corp. (the “Company”) announced today the closing of its initial public offering of 34,500,000 units, which included the full exercise of...
About LUXA
Lux Health Tech Acquisition is a newly incorporated blank check company incorporated in September 2020 as a Delaware corporation whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to capitalize on the ability of our management team to identify, acquire and operate a business at the intersection of the healthcare and technology industries. Our sponsor is Lux Encore Sponsor, LP, a Delaware limited partnership... [Read more...]
| Industry Shell Companies | IPO Date Oct 27, 2020 |
| CEO Josh DeFonzo | Country United States |
| Stock Exchange NASDAQ | Ticker Symbol LUXA |